medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 1

<< Back Next >>

Rev Invest Clin 2017; 69 (1)

Radiotherapy for Metastatic Breast Cancer in Mexico: Results from the 2015 National Survey

Álvarez-Águila N, Cook H, Prada D, Mota-García A, Herrera LA, Mohar-Betancourt A, Meneses-García A, Knaul FM

Language: English
References: 17
Page: 11-19
PDF size: 164.22 Kb.


ABSTRACT

Background: Radiation therapy is a keystone to improve survival and quality of life in breast cancer patients. In Mexico, however, scarce information is available on the obstacles faced by radio-oncologists to provide appropriate treatment. Objective: To determine the most frequent issues faced by physicians to provide radiation therapy for metastatic breast cancer in Mexico. Methods: A survey of 16 multiple-choice questions to be answered electronically by 167 radio-oncologists currently working in Mexico was designed and thereafter analyzed for differences between private and public practices, based on the responses from the surveyed participants. Results: 98.5% of surveyed responders attended patients with breast cancer. We observed a significant difference between private vs. public practice for the main difficulties in providing radiation therapy, with an increased frequency (85.8%) of “treatment cost by itself” in private practice vs. 50.7% in public practice (p ‹ 0.05). Significant differences were observed in the “Time to initiate treatment” question, with “Less than one week” as the response in 86% of those physicians in private practice vs. 50% for those in public practice (p ‹ 0.001). Conclusions: Using a survey targeted at radiooncologists, we analyzed the most important obstacles for accessing radiation therapy for metastatic breast cancer in Mexico. This information may be useful for healthcare decisions related to radiation therapy in women with breast cancer in Mexico.


REFERENCES

  1. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, et al. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012;13:e335-43.

  2. Bray F, Ren J-S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.

  3. Stewart BW, Wild CP. World Cancer Report 2014. Available at: http://publications.iarc.fr/Non-Series-Publications/World-Cancer- Reports/World-Cancer-Report-2014.

  4. A tun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16:1153-86.

  5. Mohar A, Bargalló E, Ramírez MT, Lara F, Beltrán-Ortega A. [Available resources for the treatment of breast cancer in Mexico]. Salud Publica Mex. 2009;51(Suppl 2):s263-9.

  6. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters. 200816:113-23.

  7. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. [Breast cancer in Mexico: an urgent priority]. Salud Publica Mex. 2009;51(Suppl 2):s335-44.

  8. Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015; 114:3-10.

  9. Walsh SM, Lowery AJ, Prichard RS, McDermott EW, Evoy D, Geraghty J. Postmastectomy radiotherapy: indications and implications. Surgeon. 2014;12:310-15.

  10. Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 2006;7:584-95.

  11. N igenda G, Caballero M, González-Robledo LM. [Access barriers in early diagnosis of breast cancer in the Federal District and Oaxaca]. Salud Publica Mex. 2009;51(Suppl 2):s254-62.

  12. Comparing more than two proportions. Boston University School of Public Health; Available at: http://sphweb.bumc.bu.edu/otlt/ MPH-Modules/BS/R/R6_CategoricalDataAnalysis/R6_Catego ricalDataAnalysis6.html [Accessed 2016 Jan 29].

  13. Poitevin-Chacón A, Hinojosa-Gómez J. Patterns of care of radiotherapy in México. Rep Pract Oncol Radiother. 2012;18: 57-60.

  14. Kong W, Jarvis C, Mackillop WJ. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach. Clin Oncol (R Coll Radiol). 2015;27:83-91.

  15. G il-Gil MJ, Martinez-Garcia M, Sierra A, et al. Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. Clin Transl Oncol. 2014;16: 436-46.

  16. Dixon P, Mackillop W. Could changes in clinical practice reduce waiting lists for radiotherapy? J Health Serv Res Policy. 2001;6: 70-7.

  17. Comisión Nacional de Seguridad Nuclear y Salvaguardias (CNSNS). Available at: http://www.cnsns.gob.mx/ [Accessed 2016 Nov 29].




2020     |     www.medigraphic.com